Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merz Pharmaceuticals GMBH

Division of Merz GMBH & Co. KGAA
www.merz.de

Latest From Merz Pharmaceuticals GMBH

Pipeline Watch: Phase III Zytiga, Cadazolid And Upadacitinib Results

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Keeping Track Of New Drugs: US FDA Review Queue Adds Spark Gene Therapy, Amgen Migraine Antibody, Bayer Oncologic

The latest news about novel agent applications from our FDA Performance Tracker.

Approvals Drug Review

Cuba: A Pharmaceutical Regulatory Snapshot

Despite many restrictions, the nation is a potential market for imported drugs.

Review Pathway Research & Development

Keeping Track: AbbVie Is First With HCV Genotype 4 NDA, Merck Files Keytruda For NSCLC

Weekly column reviews the latest drug development news from our FDA Performance Tracker. This week: updates on AbbVie's HCV franchise, Merck's Keytruda and a PD-L1 companion diagnostic, and botulinum toxins from Merz and Actavis.

BioPharmaceutical Regulation
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Neurology, Nervous System
  • Otolaryngology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Merz GMBH & Co. KGAA
  • Senior Management
  • Martin Zugel, PhD, CEO
    Karsten Schlemm, Head, Int'l Mktg. & Sales
    Alexander Gebauer, MD, Head, R&D
  • Contact Info
  • Merz Pharmaceuticals GMBH
    Phone: (49) 69 15 03 0
    Alfred-Wegener-Straße 2
    Frankfurt, D-60438
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register